Efficiency of Connected Health Telemonitoring Platform for Patients with High Blood Pressure

C. Morcillo, José Luis Gálvez Romero
{"title":"Efficiency of Connected Health Telemonitoring Platform for Patients with High Blood Pressure","authors":"C. Morcillo, José Luis Gálvez Romero","doi":"10.31487/j.jicoa.2020.03.09","DOIUrl":null,"url":null,"abstract":"Background: Chronic diseases are expected to double their current incidence in people over 65, before by\n2030. Cardiovascular diseases, such as ischemic heart disease and heart failure, are the most common cause\nof morbidity and mortality in developed countries and high blood pressure is the most prevalent risk factor.\nTelemedicine collects data, shares information and provides clinical care, education, public health and\nremote administrative services. Telehealth and specially connected health platforms, have the potential to\nimprove the health care system, reduce costs and increase patient satisfaction.\nMethods: During 2018, 111 patients with high blood pressure (81 (73%) men and 30 (27%) women with\nan average age 58,4 years) were selected and followed for 12 months. All patients included in the\ntelemonitoring program, received the Connected Health application on their smartphone and a bluetooth\ndevice to measure blood pressure. The application reinforces education about the disease, treatment\ncompliance, blood pressure monitoring and in case of decompensation, generates alarms that trigger a\nresponse by the medical team with video consultation.\nResults: To analyse the difference in blood pressure (systolic and diastolic), we calculate the average of the\nfirst (when patients added to the program) and last 30 measurements after the 12-month follow-up. We\nobserved a reduction of 5,7 mmHg (4%) in systolic and 4 mmHg (5%) in diastolic blood pressure (p <0.05).\nThe use of the connected health platform avoided 3,2% of costs (Blood Pressure Holter and outpatient visits)\nin one year. The patient satisfaction analysed with the Net Promoting Score of the services implicated\nincreased 2.2 points during the study period.\nConclusion: A telemonitoring platform for patients with high blood pressure, based on health\neducation, treatment compliance, blood pressure monitoring and early detection of decompensation,\nimproves blood pressure figures, reduce costs and increase patient satisfaction.\n","PeriodicalId":93027,"journal":{"name":"Journal of integrative cardiology open access","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of integrative cardiology open access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.jicoa.2020.03.09","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Chronic diseases are expected to double their current incidence in people over 65, before by 2030. Cardiovascular diseases, such as ischemic heart disease and heart failure, are the most common cause of morbidity and mortality in developed countries and high blood pressure is the most prevalent risk factor. Telemedicine collects data, shares information and provides clinical care, education, public health and remote administrative services. Telehealth and specially connected health platforms, have the potential to improve the health care system, reduce costs and increase patient satisfaction. Methods: During 2018, 111 patients with high blood pressure (81 (73%) men and 30 (27%) women with an average age 58,4 years) were selected and followed for 12 months. All patients included in the telemonitoring program, received the Connected Health application on their smartphone and a bluetooth device to measure blood pressure. The application reinforces education about the disease, treatment compliance, blood pressure monitoring and in case of decompensation, generates alarms that trigger a response by the medical team with video consultation. Results: To analyse the difference in blood pressure (systolic and diastolic), we calculate the average of the first (when patients added to the program) and last 30 measurements after the 12-month follow-up. We observed a reduction of 5,7 mmHg (4%) in systolic and 4 mmHg (5%) in diastolic blood pressure (p <0.05). The use of the connected health platform avoided 3,2% of costs (Blood Pressure Holter and outpatient visits) in one year. The patient satisfaction analysed with the Net Promoting Score of the services implicated increased 2.2 points during the study period. Conclusion: A telemonitoring platform for patients with high blood pressure, based on health education, treatment compliance, blood pressure monitoring and early detection of decompensation, improves blood pressure figures, reduce costs and increase patient satisfaction.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高血压患者联网健康远程监护平台的有效性研究
背景:预计到2030年,65岁以上人群的慢性病发病率将翻一番。心血管疾病,如缺血性心脏病和心力衰竭,是发达国家发病率和死亡率最常见的原因,高血压是最普遍的风险因素。远程医疗收集数据,共享信息,并提供临床护理、教育、公共卫生和远程管理服务。远程医疗和专门连接的医疗平台有可能改善医疗保健系统,降低成本,提高患者满意度。方法:在2018年期间,选择111名高血压患者(81名(73%)男性和30名(27%)女性,平均年龄58.4岁),并随访12个月。所有参与监测计划的患者都在智能手机上收到了“互联健康”应用程序和一个测量血压的蓝牙设备。该应用程序加强了有关疾病、治疗依从性、血压监测的教育,在失代偿的情况下,通过视频咨询生成警报,触发医疗团队的反应。结果:为了分析血压(收缩压和舒张压)的差异,我们计算了12个月随访后第一次(当患者加入该程序时)和最后30次测量的平均值。我们观察到收缩压降低了5.7mmHg(4%),舒张压降低了4mmHg(5%)(p<0.05)。使用联网健康平台在一年内避免了3.2%的成本(血压动态心电图和门诊就诊)。在研究期间,用所涉及服务的净提升分数分析的患者满意度增加了2.2分。结论:一个基于健康教育、治疗依从性、血压监测和早期发现失代偿的高血压患者远程监测平台,可以改善血压数据,降低成本,提高患者满意度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cross-Sectional, Non-Randomized, Single-Blinded, and Single-Center Study for the Accuracy of 12 Lead Smartphone ECG in the Detection of Ventricular Arrhythmias A Single Blinded, Cross-Sectional, Single-Center Study for the Validation of Atrial Fibrillation Detection using Spandan Smartphone ECG Bridging Implantable Cardioverter-Defibrillator Patients Undergoing Radiotherapy with a Wearable Cardioverter-Defibrillator Case Report of Protruded Implantable Cardiac Device through Chest in 50 Years Old Male Giant Hematoma of Rectus Abdominis Muscle in a Patient with Schistosomiasis without Periportal Abnormalities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1